The Leiden biotech company VarmX will receive 17.5 million euros from an innovation program of the European Union. The money is intended to increase the production of a drug inspired by snake venom. It prevents serious bleeding in patients taking blood thinners, especially during emergency surgery.
–
Related posts:
Incidence, R value, vaccination rate: which corona numbers count
Spanish Handball Federation Sanctioned for Violating GDPR Vaccination Certificate Requirements
Post-holiday depression affects the child while he is studying, so how can you support him to overco...
Ministry of Health and Population Shares Tips for Women's Mental Health & Minister Inspects Medical ...
